二甲双胍使用与2型糖尿病患者全膝关节置换术后并发症减少相关:倾向评分匹配分析
本研究基于Truven MarketScan数据库的回顾性队列,纳入接受单侧初次全膝关节置换术且术前诊断2型糖尿病的成人患者,按是否使用二甲双胍进行1:1倾向评分匹配,最终两组各32186例,共64372例。回归分析显示,未使用二甲双胍组在90天再入院、急诊就诊、延长住院、假体周围感染、深静脉血栓、急性肾损伤、低血糖事件及1年翻修率方面的比值比均显著升高。结论提示二甲双胍使用与多种并发症和资源利用参数降低相关。
要点
- 匹配后未使用二甲双胍组假体周围感染风险更高(OR 1.30,95%CI 1.13-1.50,p<0.001)。
- 未使用二甲双胍组1年翻修风险更高(OR 1.16,95%CI 1.01-1.33,p=0.033)。
- 未使用二甲双胍组90天再入院、急诊就诊及延长住院风险均更高。
核心结论
- 在2型糖尿病接受全膝关节置换术的患者中,二甲双胍使用与多种并发症及资源利用参数(包括假体周围感染和1年翻修率)的降低相关。
研究设计与样本
- 回顾性队列研究,使用Truven MarketScan数据库,纳入接受单侧初次全膝关节置换术且术前诊断2型糖尿病的成人患者。
- 按二甲双胍使用状态建立两组,并进行1:1倾向评分匹配,匹配因素包括年龄、性别、胰岛素状态、其他降糖药、合并症、糖尿病复杂程度和吸烟状态。
- 匹配后二甲双胍组与非二甲双胍组各32186例,共64372例。
主要发现
- 未使用二甲双胍组90天再入院风险更高(OR 1.09,95%CI 1.04-1.15,p<0.001)。
- 未使用二甲双胍组90天急诊就诊风险更高(OR 1.09,95%CI 1.04-1.14,p<0.001)。
- 未使用二甲双胍组延长住院风险更高(OR 1.12,95%CI 1.06-1.15,p<0.001)。
- 未使用二甲双胍组假体周围感染风险更高(OR 1.30,95%CI 1.13-1.50,p<0.001)。
- 未使用二甲双胍组深静脉血栓风险更高(OR 1.17,95%CI 1.09-1.26,p<0.001)。
关键数值与推荐
- 未使用二甲双胍组急性肾损伤风险更高(OR 1.21,95%CI 1.09-1.33,p<0.001)。
- 未使用二甲双胍组低血糖事件风险更高(OR 1.25,95%CI 1.01-1.54,p=0.039)。
- 未使用二甲双胍组1年翻修风险更高(OR 1.16,95%CI 1.01-1.33,p=0.033)。
临床怎么用
- 对于接受全膝关节置换术的2型糖尿病患者,二甲双胍使用可能与降低假体周围感染和1年翻修等并发症风险相关,或可考虑纳入优化方案。
局限性
- 本研究为回顾性队列研究,证据等级为治疗性III级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Diabetes is a well-established risk factor for complications following total knee arthroplasty (TKA), and the incidence of type-2 diabetes is increasing. Metformin is considered first-line therapy for type-2 diabetes and has been shown to reduce all-cause mortality and to possess anti-inflammatory properties. The impact of metformin use as it relates to outcomes following TKA is unknown. The purpose of this study was to investigate this relationship. METHODS: This is a retrospective cohort study using the Truven MarketScan database. Adult patients undergoing unilateral, primary TKA were identified. We included only patients with a preoperative diagnosis of type-2 diabetes and established 2 cohorts based on metformin status. Propensity score matching was performed to match patients who used metformin to those who did not (1-to-1). Patients were matched on factors including age, sex, insulin status, other diabetic medications, comorbidities, complexity of diabetes, and smoking status. Regression analysis was then performed on matched cohorts to examine 90-day outcomes. A subgroup analysis was performed on 1-year revision rates. RESULTS: After matching, there were 32,186 patients in both the metformin group and the no-metformin group, resulting in a total of 64,372 included patients. Baseline characteristics were similar between groups. Regression analysis, performed on matched cohorts, demonstrated that the no-metformin group had increased odds of readmission (odds ratio [OR], 1.09 [95% confidence interval (CI), 1.04 to 1.15]; p < 0.001), emergency department presentation (OR, 1.09 [95% CI, 1.04 to 1.14]; p < 0.001), extended length of stay (OR, 1.12 [95% CI, 1.06 to 1.15]; p < 0.001), periprosthetic joint infection (OR, 1.30 [95% CI, 1.13 to 1.50]; p < 0.001), deep vein thrombosis (OR, 1.17 [95% CI, 1.09 to 1.26]; p < 0.001), acute kidney injury (OR, 1.21 [95% CI, 1.09 to 1.33]; p < 0.001), hypoglycemic events (OR, 1.25 [95% CI, 1.01 to 1.54]; p = 0.039), and 1-year revision (OR, 1.16 [95% CI, 1.01 to 1.33]; p = 0.033). CONCLUSIONS: Metformin use in patients with type-2 diabetes undergoing TKA appears to be associated with lower odds of multiple complications and resource utilization parameters, including periprosthetic joint infection and 1-year revision rates. Given the frequency with which TKA is performed in patients with type-2 diabetes, this knowledge has the potential to improve optimization protocols and outcomes in this group of patients. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
引用
- Wilson JM, Farley KX, Broida SE, et al. Metformin Use Is Associated with Fewer Complications in Patients with Type-2 Diabetes Undergoing Total Knee Arthroplasty: A Propensity Score-Matched Analysis. J Bone Joint Surg Am. 2021. PMID: 33787554. doi:10.2106/JBJS.20.01535
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。